🤖 GLOBAL HEALTH OPTIMIZATION AGENT v3.0

🔬 Current Disease Focus:

Task Progress: 0%

👥 Active Problem Solvers

🌍 Experts collaborating globally

⚡ Current Task Assignment

🧬 Genetic Analysis

🔄 Matching experts to specific tasks

📊 Resource Allocation by Research Phase:

📚 Data Analysis

🧪 Experimental Design

🔬 Clinical Trials

💊 Treatment Development

Trial Search

Current Search Criteria:

Intervention: Trastuzumab injection and Pertuzumab Injection and Docetaxel Injection and Carboplatin Injection

Found 16 matching trials

Neoadjuvant Treatment Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Sequential Docetaxel Plus Trastuzumab and Pertuzumab Versus Docetaxel Plus Carboplatin Combined With Trastuzumab and Pertuzumab in HER-2 Positive Breast Cancer

PHASE3

This is a multicenter, open label, non-inferiority, randomized controlled c...

Status

Recruiting

Location

Sunyat-sen Memorial Hospital

Start Date

2021-12-20

Trial ID

NCT05159193

Treatments Being Tested

pegylated liposomal doxorubicin (PLD)cyclophosphamide (C)trastuzumab (H)pertuzumab (P)docetaxel (T)docetaxel (T)carboplatin (Cb)trastuzumab (H)pertuzumab (P)

A Study for the Neoadjuvant Treatment of Breast Cancer

PHASE4

Due to the unique advantages of albumin-bound paclitaxel, several studies i...

Status

Recruiting

Location

2nd Affiliated Hospital, School of Medicine, Zhejiang University

Start Date

2022-07-10

Trial ID

NCT05420454

Treatments Being Tested

Docetaxel Carboplatin Trastuzumab Pertuzumab Nab paclitaxel Epirubicin Cyclophosphamide Docetaxel Epirubicin Cyclophosphamide Nab paclitaxel

Optimization of Dynamic Neoadjuvant Therapy Strategies for HER2-Positive Breast Cancer Based on HER2-PET/CT Molecular Imaging

PHASE2

This study evaluates HER2-PET/CT-guided dynamic optimization of neoadjuvant...

Status

Not Yet Recruiting

Location

Multiple Locations

Start Date

2026-05-01

Trial ID

NCT07527806

Treatments Being Tested

Trastuzumab (Herceptin)Pertuzumab Combination product: Trastuzumab + Pertuzumab Docetaxel or Nab-paclitaxel carboplatin CDK4/6 inhibitor Aromatase Inhibitor (AI)ADC

A Study for the Adjuvant Treatment of Breast Cancer

PHASE4

Studies on postoperative adjuvant albumin paclitaxel in domestic breast can...

Status

Recruiting

Location

2nd Affiliated Hospital, School of Medicine, Zhejiang University

Start Date

2022-07-10

Trial ID

NCT05420467

Treatments Being Tested

Docetaxel Carboplatin Trastuzumab Pertuzumab Nab paclitaxel Epirubicin Cyclophosphamide Docetaxel Epirubicin Cyclophosphamide Nab paclitaxel Cyclophosphamide

A Phase II/III Clinical Study to Evaluate the Efficacy and Safety of HLX87in Combination With HLX22 or Pertuzumab in the Neoadjuvant Therapy of HER2-Positive Bresat Cancer

PHASE2

The study is being conducted to evaluate the clinical efficacy of HLX87 in ...

Status

Not Yet Recruiting

Location

Multiple Locations

Start Date

2026-01-27

Trial ID

NCT07294534

Treatments Being Tested

HLX87+HX22 HLX87 + Pertuzumab TCbHP

Efficacy of Nab-PHP Versus TCbHP in Neoadjuvant Therapy for HER2-positive Early Breast Cancer

PHASE3

The aim of this study is to evaluate the efficacy of nab-paclitaxel (on day...

Status

Recruiting

Location

Henan cancer hospital

Start Date

2025-06-24

Trial ID

NCT07057427

Treatments Being Tested

Nab paclitaxel Docetaxel and Carboplatin Trastuzumab + Pertuzumab

A Clinical Study to Explore the Safety, Tolerability, and Efficacy of Recombinant Human nsIL12 Oncolytic Adenovirus Injection (BioTTT001) Combined With Neoadjuvant Treatment for Locally Advanced Breast Cancer

PHASE1

A clinical study to explore the safety, tolerability, and efficacy of recom...

Status

Withdrawn

Location

The Second People's Hospital of Shandong Province

Start Date

2025-03-26

Trial ID

NCT07150767

Treatments Being Tested

BioTTT001 injection

A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer

PHASE3

This is a Phase IIIb, multinational, multicenter, randomized, open-label st...

Status

Completed

Location

Centro de Investigaciones Médicas y Desarrollo LC S.R.L

Start Date

2022-07-05

Trial ID

NCT05415215

Treatments Being Tested

Fixed Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Use (PH FDC SC)Pertuzumab IV Trastuzumab IV Trastuzumab Emtansine Investigator's Choice of Chemotherapy Surgery Radiotherapy

Docetaxel, Carboplatin, Trastuzumab, and Pertuzumab With or Without Estrogen Deprivation in Treating Patients With Hormone Receptor-Positive, HER2-Positive Operable or Locally Advanced Breast Cancer

PHASE3

This randomized phase III trial studies docetaxel, carboplatin, trastuzumab...

Status

Completed

Location

Fairbanks Memorial Hospital

Start Date

2014-02-18

Trial ID

NCT02003209

Treatments Being Tested

Aromatase Inhibition Therapy Carboplatin Cytology Specimen Collection Procedure Docetaxel Goserelin Acetate Laboratory Biomarker Analysis Pertuzumab Quality-of-Life Assessment Therapeutic Conventional Surgery Trastuzumab Whole Breast Irradiation

Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer

PHASE2

This phase II trial studies the immunologic response and side effects of us...

Status

Recruiting

Location

Fred Hutch/University of Washington Cancer Consortium

Start Date

2022-04-20

Trial ID

NCT04329065

Treatments Being Tested

pUMVC3-IGFBP2-HER2-IGF1R Plasmid DNA Vaccine Paclitaxel Trastuzumab Pertuzumab Docetaxel Carboplatin Ultrasound Imaging Biopsy Procedure Biospecimen Collection

Previous Next